Heterozygous RELA mutations cause early-onset systemic lupus erythematosus by hijacking the NF-κB pathway towards transcriptional activation of type-I Interferon genes
Authors:
- Laura BarnabeiLBLaura Barnabei
- Hicham LamriniHLHicham Lamrini
- Mathieu CastelaMCMathieu Castela
- Nadia JeremiahNJNadia Jeremiah
- Marie-Claude StolzenbergMSMarie-Claude Stolzenberg
- Loïc ChentoutLCLoïc Chentout
- Sidonie JacquesSJSidonie Jacques
- Amine BouafiaABAmine Bouafia
- Aude Magérus-ChatinetAude Magérus-Chatinet
- Matthieu MoncanMMMatthieu Moncan
- Sajedeh MirshahvaladSMSajedeh Mirshahvalad
- Olivier PelléOPOlivier Pellé
Preprint
Abstract
Systemic Lupus Erythematosus (SLE) is an autoimmune and inflammatory disease characterized by uncontrolled production of autoantibodies and inflammatory cytokines such as the type-I interferons. Due to the lack of precise pathophysiological mechanisms, treatments are based on broad unspecific immunossupression. To identify genetic factors associated with SLE we performed whole exome sequencing and identified two RELA heterozygous activating mutations in 3 early-onset and familial SLE cases. The corresponding RELA/p65 mutant were abundant in the nucleus but poorly activate transcription of genes controlled by NF-κB consensus sequences. The co-expression of the mutant and wild-type RELA/p65 strongly activated the expression of genes controlled by the IFNα-consensus sequences. These molecular mechanisms lead to the overproduction of type-I IFN in the patients’ cells. Our findings highlight a novel mechanism of autoimmunity where these new RELA mutants are transactivating the type-I IFN genes and are thus promoting type-I interferon production and early-onset SLE, thereby paving the way to the identification of new and specific therapeutic targets. Summary: Heterozygous RELA mutations are associated with Systemic Lupus Erythematosus, with increased expression of genes controlled by the IFNα-consensus sequences.Keywords
This publication has 39 references indexed in Scilit:
- Impact of C1q deficiency on the severity and outcome of childhood systemic lupus erythematosusInternational Journal of Rheumatic Diseases, 2010
- A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosusNature Genetics, 2009
- Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosusNature Genetics, 2008
- Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other lociNature Genetics, 2008
- Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarrayGenes & Immunity, 2003
- Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus BloodJournal of Experimental Medicine, 2003
- Inhibition of Tumor Necrosis Factor-α-induced Nuclear Translocation and Activation of NF-κB by DehydroxymethylepoxyquinomicinJournal of Biological Chemistry, 2002
- Inhibition of cytokine-induced nitric oxide synthase expression by gene transfer of adenoviral IκBαSurgery, 1999
- NF-κB Controls Expression of Inhibitor IκBα: Evidence for an Inducible Autoregulatory PathwayScience, 1993
- Immune Interferon in the Circulation of Patients with Autoimmune DiseaseNew England Journal of Medicine, 1979